Livagen (KEDA) record · updated 20h ago

Healing & recoveryMetabolic & appetiteGrade D · emergingResearch use only

What is Livagen (KEDA) used for?

Livagen (KEDA) is a short synthetic peptide bioregulator studied for liver support, immune modulation, and chromatin-level gene regulation in aging research.

Primarily researched for · Healing & recovery

Development stage

where Livagen (KEDA) sits between preclinical work and regulatory approval

1Current
Preclinical
Animal / in-vitro work
2Not reached
Phase 1
Safety in humans
3Not reached
Phase 2
Efficacy signal
4Not reached
Phase 3
Confirmatory trials
5Not reached
Approved
Cleared by a regulator

Stage is inferred from the highest trial phase in the indexed corpus. It describes the research record, not a recommendation.

Identity

NameLivagen (KEDA)

Chain length—

Molecular weight461.5 Da

FormulaC18H31N5O9

Structure typeSmall molecule

ClassLongevity

Research levelModerate Research

Discovered byCurated master list · 2026

Mass and formula from PubChem CID 87919683. No verified residue count for this compound.

Pharmacology

Mechanism—

Route—

Half-life—

Time to peak—

Duration—

Extraction confidence—

Effect profile · 0–5

These seven scores are generated by the Librarian — an autonomous agent running GPT-4o over the indexed studies, trials and label data for this compound. No human assigns them and no community vote moves them. Last recomputed Jul 27, 2026. How this works →

Research stats

Total studies0

Human / animal / cellular0 / 0 / 0

Highest trial phase—

Years covered1998–2020

Latest study—

Publication history

No publication years on file

——

Research funding

—no NIH grants found

Safety signals

FAERS reportsnone recorded

Serious AEs in animal work—

Community reports—

Positive —Neutral —Negative —

Records

ChEMBL ClinicalTrials.gov DrugBank Google Scholar PubChem PubMed · 0 Semantic Scholar UniProt

Study register

0 rowsOpen in the library →

Study	Type	Year	Summary depth
No approved studies filed yet — the Librarian is still searching.

What people are saying

anecdotal · not evidence

Unverified first-hand accounts from public forums. These are not studies: nobody checked what was taken, whether it was what the label said, or what else was going on. They count for nothing in the evidence grade above and are shown because a reader searching Livagen (KEDA) will meet them anyway, and meeting them next to a graded evidence base is better than meeting them alone.

Community collection has not run yet, so this is an empty shelf rather than a quiet one — nothing has been read, and no conclusion about how much Livagen (KEDA) is discussed should be drawn from it.